Literature DB >> 22926710

Hypodense regions in unenhanced CT identify nonviable myocardium: validation versus 18F-FDG PET.

Tobias A Fuchs1, Jelena R Ghadri, Julia Stehli, Catherine Gebhard, Egle Kazakauskaite, Bernd Klaeser, Oliver Gaemperli, Michael Fiechter, Philipp A Kaufmann.   

Abstract

PURPOSE: The aim of the present study was to evaluate the accuracy of hypodense regions in non-contrast-enhanced cardiac computed tomography (unenhanced CT) to identify nonviable myocardial scar tissue.
METHODS: Hypodense areas were visually identified in unenhanced CT of 80 patients in the left ventricular anterior, apical, septal, lateral and inferior myocardium and CT density was measured in Hounsfield units (HU). Findings were compared to (18)F-fluorodeoxyglucose uptake by positron emission tomography (FDG PET), which served as the standard of reference to distinguish scar (<50 % FDG uptake) from viable tissue (≥50 % uptake).
RESULTS: Visually detected hypodense regions demonstrated a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 74, 97, 84 and 94 %, respectively. A receiver-operating characteristic (ROC) curve analysis revealed a cutoff value of mean HU at <28.8 for predicting scar tissue with an area under the curve of 0.93 yielding a sensitivity, specificity, PPV and NPV of 94, 90, 67 and 99 %, respectively.
CONCLUSION: Hypodense regions in unenhanced cardiac CT scans allow accurate identification of nonviable myocardial scar tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926710     DOI: 10.1007/s00259-012-2212-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy.

Authors:  Stephen G Sawada; Stephen J Lewis; Judy Foltz; Agota Ando; Samer Khouri; Shawn Kaser; Irmina Gradus-Pizlo; William Gill; Naomi Fineberg; Douglas Segar; Harvey Feigenbaum
Journal:  Am J Cardiol       Date:  2002-04-01       Impact factor: 2.778

2.  American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy.

Authors:  Gary V Heller; Jonathan Links; Timothy M Bateman; Jack A Ziffer; Edward Ficaro; Mylan C Cohen; Robert C Hendel
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Effective dose from radiopharmaceuticals.

Authors:  L Johansson; S Mattsson; B Nosslin; S Leide-Svegborn
Journal:  Eur J Nucl Med       Date:  1992

4.  Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events.

Authors:  Victor Y Cheng; Damini Dey; Balaji Tamarappoo; Ryo Nakazato; Heidi Gransar; Romalisa Miranda-Peats; Amit Ramesh; Nathan D Wong; Leslee J Shaw; Piotr J Slomka; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2010-04

5.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

6.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

7.  Chronic myocardial infarction detection and characterization during coronary artery calcium scoring acquisitions.

Authors:  Gastón A Rodríguez-Granillo; Miguel A Rosales; Paola Renes; Eduardo Diez; Jorge Pereyra; Estela Gomez; Gustavo De Lillo; Elina Degrossi; Alfredo E Rodriguez; Eugene P McFadden
Journal:  J Cardiovasc Comput Tomogr       Date:  2009-12-21

8.  The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program.

Authors:  K Yano; C J MacLean
Journal:  Arch Intern Med       Date:  1989-07

Review 9.  Stunning, hibernation, and assessment of myocardial viability.

Authors:  Paolo G Camici; Sanjay Kumak Prasad; Ornella E Rimoldi
Journal:  Circulation       Date:  2008-01-01       Impact factor: 29.690

10.  Non-contrast cardiac computed tomography can accurately detect chronic myocardial infarction: Validation study.

Authors:  Mohit Gupta; Jigar Kadakia; Yalcin Hacioglu; Naser Ahmadi; Amish Patel; Taeyoung Choi; Gregg Yamada; Matthew Budoff
Journal:  J Nucl Cardiol       Date:  2010-12-03       Impact factor: 5.952

View more
  2 in total

1.  Artifact-free quantitative cardiovascular PET/MR imaging: An impossible dream?

Authors:  Habib Zaidi; Rene Nkoulou
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

Review 2.  Myocardial perfusion imaging with cardiac computed tomography: state of the art.

Authors:  Amit R Patel; Nicole M Bhave; Victor Mor-Avi
Journal:  J Cardiovasc Transl Res       Date:  2013-08-21       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.